Category: Biotechnology
Biotechnology market research reports by DelveInsight
-
P38 mitogen-activated protein (MAP) kinase inhibitors - Pipeline Insight, 2022
“ P38 mitogen-activated protein (MAP) kinase inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in P38 mitogen-activated protein (MAP) kinase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2022
“ Anti-CD28 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022
“ Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Hematopoietic progenitor kinase 1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022
“ Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022 ” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Anti-CD279 (PD-1) Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2022
“ Anti-CD3 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
TrkC receptor antagonists - Pipeline Insight, 2022
“ TrkC receptor antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in TrkC receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Nerve Repair and Regeneration- Market Insight, Competitive Landscape and Market Forecast- 2026
Nerve Repair and Regeneration- Market Insight, Competitive Landscape and Market Forecast- 2026 Nerve Repair and Regeneration Market By Surgery (Direct Neuropathy [Epineural Repair, Perineural Repair, Group Fascicular Repair], Nerve Grafting [Autografts, Allografts, And Xenografts], Stem Cell Therapy ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2022
“ Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2022
“ T-cell Surface Glycoprotein CD4- Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in T-cell Surface Glycoprotein CD4 pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032
DelveInsight's "" Graft Versus Host Disease (GvHD)- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Graft Versus Host Disease (GvHD), historical and forecasted epidemiology as well as the Graft Versus Host Disease (GvHD) market trends in th ... Read More
-
Liquid Biopsy in Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast-2026
Liquid Biopsy in Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast-2026 Liquid Biopsy in Cancer Diagnostics Market By Type (Product Type [Instruments And Reagents & Kits] And Services), By Sample Type (Blood, Urine, And Saliva), By Biomarker Type (Circulating Tumor Cell ... Read More
-
G Protein-Coupled Receptor (GPCR) - Epidemiology Forecast - 2032
DelveInsight's "" G Protein-Coupled Receptor (GPCR) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted G Protein-Coupled Receptor (GPCR) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the U ... Read More
-
CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast - 2032
DelveInsight's "" CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CD19/CD20 Bi-specific CAR-T epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdo ... Read More
-
CD137 Agonist Antibody - Pipeline Insight, 2022
“ CD137 Agonist Antibody - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in CD137 Agonist Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022
“ Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The report provides detailed coverage of the pipeline landsca ... Read More
-
Immunoglobulin inhibitors - Pipeline Insight, 2022
“ Immunoglobulin inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Immunoglobulin inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Exosomes - Epidemiology Forecast - 2032
DelveInsight's "" Exosomes - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Exosomes epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • T ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2022
“ Anti-CD52 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Trk (TrkB) receptor antagonists - Pipeline Insight, 2022
“ Trk (TrkB) receptor antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Trk (TrkB) receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast to 2032
DelveInsight's "" PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted PCSK9 Inhibitors (PCSK9i) disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the U ... Read More
-
HER2Negative Metastatic Breast Cancer - Epidemiology Forecast to 2032
DelveInsight's "" HER2Negative Metastatic Breast Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted HER2Negative Metastatic Breast Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, a ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2022
“ Anti GM-CSF Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2022
“ Anti-CD33 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026 Biologics Market By Product Type (Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, And Others), By Application (Oncology, Immunology, Infectious Diseases, Neurological Diseas ... Read More
-
5-HT2A Agonists - Pipeline Insight, 2022
“ 5-HT2A Agonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in 5-HT2A Agonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by p ... Read More
Research Assistance
